Verified Researcher Certificate
Active ResearchRank profile with at least one indexed scholarly output
RESEARCHER PUBLIC RESEARCH PROFILE● Verified public profile
RRK-A-5100-7278-79
Ajay K. Singh
Works396
Citations16,148
h-index54
i10-index145
2-year citedness3.64
Mean FWCI*20.66
Top 1%*12
Top 10%*23
ResearchRank IDRRK-A-5100-7278-79
Observed nameAjay K. Singh
ORCID0000-0003-2933-4058
Current / last-known institutionBrigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Mass General Brigham
Research topicsDialysis and Renal Disease Management · Erythropoietin and Anemia Treatment · Chronic Kidney Disease and Diabetes · Iron Metabolism and Disorders · Acute Kidney Injury Research
Name variantsA K Singh, A Singh, A. K. Singh, A. Singh, A.K Singh, A.K. Singh, A.K. Singh for the PROMPT Study Group, AJAY K. SINGH, Ajay K Singh, Ajay K. Singh, Ajay Kumar Singh, Ajay Singh
FULL PROFILE ANALYSIS
Ajay K. Singh - detailed research intelligence
Identity, scholarly output, impact indicators, affiliations, topics and publication evidence for this ResearchRank record.
Profile typeResearcher
Works396
Citations16,148
h-index54
i10-index145
Current / last-known affiliationBrigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Mass General Brigham
ORCID0000-0003-2933-4058
Name variantsA K Singh, A Singh, A. K. Singh, A. Singh, A.K Singh, A.K. Singh, A.K. Singh for the PROMPT Study Group, AJAY K. SINGH, Ajay K Singh, Ajay K. Singh, Ajay Kumar Singh, Ajay Singh
Primary research topics
Dialysis and Renal Disease ManagementErythropoietin and Anemia TreatmentChronic Kidney Disease and DiabetesIron Metabolism and DisordersAcute Kidney Injury Research
Dialysis and Renal Disease ManagementErythropoietin and Anemia TreatmentChronic Kidney Disease and DiabetesIron Metabolism and DisordersAcute Kidney Injury Research
RESEARCH ACHIEVEMENT SNAPSHOT
Evidence-backed profile highlights
This public profile presents scholarly evidence and recognition indicators without displaying certificate prices or checkout controls.
Research Output Certificate
At least 10 indexed scholarly works
Citation Impact Certificate
At least 100 indexed citations
h-index Achievement Certificate
h-index of 10 or higher
Distinguished Researcher Certificate
h-index of 20+ and at least 1,000 indexed citations
Sustained Research Output Certificate
At least 50 indexed scholarly outputs
Distinguished Research Impact Certificate
At least 5,000 indexed citations and h-index of 30+
Public profile: Research metrics and recognition evidence are shown for professional sharing. Commercial pricing and registration controls are intentionally omitted.
Extended publication analytics and related-profile intelligence are loading in the background. The full profile details below remain available even if the live analytics service is temporarily slow.
TOP-CITED OUTPUT
Full profile view · up to 25 leading worksResearch works
Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseErratum · 2006 · 2,762 citations · Open access · Full text ↗
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney DiseaseArticle · 2009 · 2,096 citations · Open access · FWCI 125.3282 · Full text ↗
Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomesArticle · 2008 · 527 citations · Open access · FWCI 32.4609 · Full text ↗
Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies ConferenceArticle · 2016 · 483 citations · Open access · FWCI 42.1496 · Full text ↗
Erythropoietic Response and Outcomes in Kidney Disease and Type 2 DiabetesArticle · 2010 · 473 citations · Open access · FWCI 30.6258 · Full text ↗
Epidemiology and risk factors of chronic kidney disease in India – results from the SEEK (Screening and Early Evaluation of Kidney Disease) studyArticle · 2013 · 421 citations · Open access · FWCI 12.619 · Full text ↗
A Comparison of Prediction Equations for Estimating Glomerular Filtration Rate in Adults without Kidney DiseaseArticle · 2003 · 411 citations · FWCI 21.5959 · Full text ↗
Ferric Gluconate Is Highly Efficacious in Anemic Hemodialysis Patients with High Serum Ferritin and Low Transferrin SaturationArticle · 2007 · 391 citations · FWCI 25.7652 · Full text ↗
Hypertension in the Developing World: Challenges and OpportunitiesReview · 2009 · 305 citations · FWCI 1.9074 · Full text ↗
Metabolic syndrome and chronic kidney diseaseReview · 2013 · 299 citations · FWCI 6.9877 · Full text ↗
KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKDArticle · 2013 · 270 citations · FWCI 10.0428 · Full text ↗
The American college of rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trialsArticle · 2006 · 263 citations · FWCI 8.7529 · Full text ↗
Frequency of and risk factors for poor cognitive performance in hemodialysis patientsArticle · 2013 · 258 citations · Open access · FWCI 13.4629 · Full text ↗
Daprodustat for the Treatment of Anemia in Patients Undergoing DialysisArticle · 2021 · 250 citations · Open access · FWCI 27.873 · Full text ↗
Combination Therapy of Prednisone and ACE Inhibitor Versus ACE-Inhibitor Therapy Alone in Patients With IgA Nephropathy: A Randomized Controlled TrialArticle · 2008 · 237 citations · FWCI 11.2574 · Full text ↗
Daprodustat for the Treatment of Anemia in Patients Not Undergoing DialysisArticle · 2021 · 234 citations · Open access · FWCI 26.3505 · Full text ↗
Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK studyArticle · 2009 · 220 citations · FWCI 3.9028 · Full text ↗
Serum Amyloid P Inhibits Fibrosis Through FcγR-Dependent Monocyte-Macrophage Regulation in VivoArticle · 2009 · 206 citations · Open access · FWCI 9.3301 · Full text ↗
Ferric Gluconate Reduces Epoetin Requirements in Hemodialysis Patients with Elevated FerritinArticle · 2008 · 181 citations · Open access · FWCI 13.85 · Full text ↗
Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceArticle · 2023 · 149 citations · Open access · FWCI 30.6576 · Full text ↗
PROMINENT AND SUSTAINED UP-REGULATION OF GP130-SIGNALING CYTOKINES AND OF THE CHEMOKINE MIP-2 IN MURINE RENAL ISCHEMIA-REPERFUSION INJURY1Article · 2000 · 149 citations · FWCI 7.0602 · Full text ↗
Safety of Ferumoxytol in Patients With Anemia and CKDArticle · 2008 · 146 citations · FWCI 8.2234 · Full text ↗
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental GlomerulosclerosisArticle · 2017 · 137 citations · Open access · FWCI 9.787 · Full text ↗
Cardiovascular Toxicity of Epoetin-Alfa in Patients with Chronic Kidney DiseaseArticle · 2013 · 132 citations · FWCI 8.8472 · Full text ↗
Cognitive Function and All-Cause Mortality in Maintenance Hemodialysis PatientsArticle · 2014 · 130 citations · Open access · FWCI 7.1155 · Full text ↗